Evidence check: FTO in the context of menopause

The FTO gene is one of the most studied loci in relation to obesity and body weight. Variants such as rs9939609 are associated with increased BMI, but the effect size is modest and strongly modulated by lifestyle factors like diet and physical activity. In the context of menopause, hormonal shifts (especially estrogen decline) alter fat distribution and energy expenditure – independently of FTO genotype. Some research suggests that women carrying FTO risk alleles may be more prone to weight gain during menopause, but the evidence is not robust enough for personalized recommendations. A DNA test for FTO alone does not provide clinically actionable information for menopause management. Prioritizing regular exercise, balanced nutrition, and medical supervision is far more impactful. MyBody-X tests are not medical diagnostics.